Gastric Microbiome and Gastric Cancer

AbstractCancer of the stomach is the fourth most common cancer worldwide. The single strongest risk factor for gastric cancer is Helicobacter pylori–associated chronic gastric inflammation. Among persons with H. pylori infection, strain-specific components, host immune responses, and environmental factors influence the risk for gastric disease, including adenocarcinoma of the stomach, although only a small proportion of infected persons develop the malignancy. Recent advances in DNA sequencing technology have uncovered a complex community of noncultivatable inhabitants of the human stomach. The interaction between these inhabitants, collectively referred to as the gastric microbiota, and H. pylori likely affects gastric immunobiology and possibly the sequelae of H. pylori infection. Thus, characterization of the gastric microbiota in subjects with and without H. pylori infection could provide new insight into gastric homeostasis and the pathogenesis of H. pylori–associated disease, including gastric cancer.

[1]  S. Reuter,et al.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. , 2012, The Journal of clinical investigation.

[2]  M. Mohagheghi,et al.  A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. , 2007, Gastroenterology.

[3]  Y. Shiratori,et al.  Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori , 2002, Gut.

[4]  M. Kubo,et al.  A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: The Hisayama study , 2006, International journal of cancer.

[5]  T. Azuma,et al.  Gastric leptin and Helicobacter pyloriinfection , 2001, Gut.

[6]  K. Kangawa,et al.  Ghrelin: structure and function. , 2005, Physiological reviews.

[7]  T. Furuta,et al.  Effect of Helicobacter pylori infection and its eradication on nutrition , 2002, Alimentary pharmacology & therapeutics.

[8]  M. Blaser,et al.  What are the consequences of the disappearing human microbiota? , 2009, Nature Reviews Microbiology.

[9]  C. Whitchurch,et al.  Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells , 2010, Cellular microbiology.

[10]  T. A. Nagy,et al.  Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. , 2008, Cancer research.

[11]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[12]  M. P. Tan,et al.  Chronic Helicobacter pylori Infection Does Not Significantly Alter the Microbiota of the Murine Stomach , 2006, Applied and Environmental Microbiology.

[13]  T. Wang,et al.  Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. , 2011, Gastroenterology.

[14]  T. Cover,et al.  Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori–infected children , 2013, Mucosal Immunology.

[15]  H. Kowarzyk.  Structure and Function. , 1910, Nature.

[16]  O. Herbarth,et al.  Five- to 7-Year-Old Children With Helicobacter pylori Infection Are Smaller Than Helicobacter-Negative Children: A Cross-Sectional Population-Based Study of 3,315 Children , 2001, Journal of pediatric gastroenterology and nutrition.

[17]  D. Falush,et al.  Plastic cells and populations: DNA substrate characteristics in Helicobacter pylori transformation define a flexible but conservative system for genomic variation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Oda,et al.  Non-Helicobacter Bacterial Flora Rarely Develops in the Gastric Mucosal Layer of Children , 2006, Digestive Diseases and Sciences.

[19]  P. Harris,et al.  Role of childhood infection in the sequelae of H. pylori disease , 2013, Gut microbes.

[20]  R. Peek,et al.  Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.

[21]  E. Gamazon,et al.  Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis , 2013, Gut.

[22]  Elisabeth M Bik,et al.  Molecular analysis of the bacterial microbiota in the human stomach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Yu Chen,et al.  Inverse associations of Helicobacter pylori with asthma and allergy. , 2007, Archives of internal medicine.

[24]  R. Haas,et al.  Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation , 2003, Science.

[25]  M. Stephens,et al.  Traces of Human Migrations in Helicobacter pylori Populations , 2003, Science.

[26]  T. A. Nagy,et al.  Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. , 2009, The Journal of infectious diseases.

[27]  Daniel Falush,et al.  An African origin for the intimate association between humans and Helicobacter pylori , 2007, Nature.

[28]  A. Svennerholm,et al.  Mucosal FOXP3-Expressing CD4+ CD25high Regulatory T Cells in Helicobacter pylori-Infected Patients , 2005, Infection and Immunity.

[29]  R. Wysocki,et al.  Molecular Profiling of Activated Neurons by Phosphorylated Ribosome Capture , 2012, Cell.

[30]  Janet K. Jansson,et al.  Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. , 2009, Journal of medical microbiology.

[31]  Mark J. Miller,et al.  Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. , 2010, Gastroenterology.

[32]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[33]  G. Wilson,et al.  Ref‐1/Ape is critical for formation of the hypoxia‐inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  H. Sugihara,et al.  Beta-Catenin Expression in Intramucosal Neoplastic Lesions of the Stomach , 2003, Oncology.

[35]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[36]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[37]  Naomi Ohnishi,et al.  Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse , 2008, Proceedings of the National Academy of Sciences.

[38]  T. Cover,et al.  Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. , 2003, Cancer research.

[39]  A. Sonnenberg,et al.  Opposing time trends of peptic ulcer and reflux disease , 1998, Gut.

[40]  R. Peek,et al.  cag+ Helicobacter pylori Induce Transactivation of the Epidermal Growth Factor Receptor in AGS Gastric Epithelial Cells* , 2001, The Journal of Biological Chemistry.

[41]  H. Randeva,et al.  Plasma ghrelin following cure of Helicobacter pylori. , 2003, Gut.

[42]  P. Malfertheiner,et al.  The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany , 2000, International journal of cancer.

[43]  T. Wang,et al.  Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. , 2008, Cancer research.

[44]  M. Gail,et al.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.

[45]  M. Blaser,et al.  Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.

[46]  R. Lorenz,et al.  Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. , 2008, Gastroenterology.

[47]  L. Bravo,et al.  Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk , 2011, Gut.

[48]  N. Murata‐Kamiya.  Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. , 2011, Microbes and infection.

[49]  K. Ottemann,et al.  The Degree of Helicobacter pylori-Triggered Inflammation Is Manipulated by Preinfection Host Microbiota , 2013, Infection and Immunity.

[50]  Yi-ping Lin,et al.  The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population , 2005, Clinical Cancer Research.

[51]  C. Mowat,et al.  Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. , 2000, Gastroenterology.

[52]  M. Blaser,et al.  Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. , 2009, The Journal of clinical investigation.

[53]  Eoin L Brodie,et al.  Structure of the human gastric bacterial community in relation to Helicobacter pylori status , 2011, The ISME Journal.

[54]  U. Göbel,et al.  Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. , 2006, FEMS immunology and medical microbiology.

[55]  J. Parsonnet,et al.  Helicobacter pylori and gastric adenocarcinoma. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[56]  C. Sasakawa,et al.  Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. , 2009, Cell host & microbe.

[57]  C. Prinz,et al.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[58]  H. Isomoto,et al.  Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. , 2004, The American journal of medicine.